NEW YORK (GenomeWeb News) – For the second month in a row, shares of Myriad Genetics rose sharply, pacing gainers in the GenomeWeb Daily News Index.

The GWDN Index climbed 5 percent in February, outpacing the Down Jones Industrial Average (+ 4 percent) and matching the Nasdaq (+ 5 percent) for the month. However, it trailed the Nasdaq Biotech Index, which gained 8 percent month over month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.